Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

Br J Cancer. 2003 Sep 15;89(6):1140-1; author reply 1141-2. doi: 10.1038/sj.bjc.6601176.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Camptothecin / analogs & derivatives*
  • Camptothecin / therapeutic use*
  • Cisplatin / therapeutic use*
  • Clinical Trials, Phase II as Topic
  • Drug Resistance, Neoplasm*
  • Germany
  • Humans
  • Irinotecan
  • Male
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasms, Germ Cell and Embryonal / drug therapy*
  • Neoplasms, Germ Cell and Embryonal / pathology
  • Testicular Neoplasms / drug therapy*
  • Testicular Neoplasms / pathology
  • Testicular Neoplasms / secondary

Substances

  • Irinotecan
  • Cisplatin
  • Camptothecin